Epratuzumab Tesirine

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
BPS-82919-1	1 mg	-	-	-	3 - 15 business days*		8,850.00€
BPS-82919-2	5 mg	-	-	-	3 - 15 business days*		18,680.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Epratuzumab Tesirine (ADCT-602) is a novel CD22-targeted ADC. Epratuzumab Tesirine contains a PBD... more

Close menu

Product information "Epratuzumab Tesirine"

Epratuzumab Tesirine (ADCT-602) is a novel CD22-targeted ADC. Epratuzumab Tesirine contains a PBD dimer and a payload SG32491.

Keywords:	Anti-CD22, Anti-BL-CAM, Anti-SIGLEC2, Anti-Siglec-2, Anti-B-cell receptor CD22, Anti-T-cell surface antigen Leu-14, Anti-B-lymphocyte cell adhesion molecule, Anti-Sialic acid-binding Ig-like lectin 2,
Supplier:	BPS Bioscience
Supplier-Nr:	82919

Properties

Application:	Cancer therapy target studies
Conjugate:	No
Species reactivity:	human

Database Information

KEGG ID :	K06467 \| Matching products
UniProt ID :	P20273 \| Matching products
Gene ID :	GeneID 933 \| Matching products

Handling & Safety

Storage:	+20°C
Shipping:	+20°C (International: +20°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 82919 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Epratuzumab Tesirine"

Write a review